Comments

Taysha Gene Therapies Stock Guidance

TSHANASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$1.54
-0.08-4.94%
Pre-Market: 6:11 PM EDT
Q4 2024 Earnings were released on Wed Feb 26th, before the market open
The most recent conference call was at 8:30 AM, 1 day ago Click to view past webcast
Taysha Gene Therapies (TSHA) ForecastNewsEarningsTaysha Gene Therapies (TSHA) Options

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Taysha Gene Therapies Stock Guidance | NASDAQ:TSHA | Benzinga

Taysha Gene Therapies issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Taysha Gene Therapies (TSHA)?

A

There have been no specific sales or earnings guidance reported for Taysha Gene Therapies in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved